# A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blood of People With Overweight or Obesity Who Receive 2 Preparations of the Medicine

> **NCT06642571** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 46 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** NNC0519-0130 B
- **DRUG:** NNC0519-0130 C

## Key facts

- **NCT ID:** NCT06642571
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-15
- **Primary completion:** 2025-05-17
- **Final completion:** 2025-05-31
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06642571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06642571, "A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blood of People With Overweight or Obesity Who Receive 2 Preparations of the Medicine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06642571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*